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Abstract
The role of dietary fiber in supporting healthy gut microbiota and overall well-being of the
host has been revealed in several studies. Here, we show the effect of a bacterial polyfruc-
tan levan on the growth dynamics and metabolism of fecal microbiota in vitro by using iso-
thermal microcalorimetry. Eleven fecal samples from healthy donors were incubated in
phosphate-buffered defined medium with or without levan supplementation and varying
presence of amino acids. The generation of heat, changes in pH and microbiota composi-
tion, concentrations of produced and consumed metabolites during the growth were deter-
mined. The composition of fecal microbiota and profile of metabolites changed in response
to substrate (levan and amino acids) availability. The main products of levan metabolism
were acetic, lactic, butyric, propionic and succinic acids and carbon dioxide. Associated
growth of levan-degrading (e.g. Bacteroides) and butyric acid-producing (e.g. Faecalibac-
terium) taxa was observed in levan-supplemented media. The study shows that the capac-
ity of levan and possibly also other dietary fibers/prebiotics to modulate the composition and
function of colon microbiota can be predicted by using isothermal microcalorimetry of fecal
samples linked to metabolite and consortia analyses.
Introduction
The breakdown of complex carbohydrates is one of the most important processes carried out
by colon microbiota that plays a central role in biochemical and physiological processes not
only in the colon, but also in other places of the body. Fermentation processes in the colon are
regulated, in large part, through substrate availability [1]. Microbially accessible carbohydrates
(MACs) are carbohydrates that are metabolically available to gut microbes. The MACs include
dietary fibers (food components which are resistant to degradation and absorption in the
upper digestive tract of the host), carbohydrate components of intestinal mucus and sugars
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produced by microbes within the intestine. Dietary fibers originate from a variety of sources
including plants, animal tissues and food-borne microbes. The amount of carbohydrates
metabolized depends upon composition of the person’s microbiota and differs largely between
individuals [2].
Diet is among the easiest way to manipulate the composition and activity of gut microbiota
[3–6]. However, little is known about how these changes can be correctly predicted [3]. The
microbial fermentation of complex dietary components in the colon occurs in trophic chains
and insight into this multispecies-aided conversion is essential to understand the impact of the
diet on health [7]. Co-inhabiting groups can efficiently use limited resources through metabo-
lite sharing and exchange, thus providing a survival advantage and enabling coexistence of dif-
ferent bacterial species in diverse niches [8]. Fermentation of complex carbohydrates by colon
microbiota results in production of organic acids, especially acetate, propionate and butyrate
that fuel the enterocytes but also have—signaling functions for systemic immune and meta-
bolic responses [7,9,10].
The effect of inulin (β-2,1-D-fructan) on dynamics and metabolism of fecal microbiota has
been studied extensively in vitro and in vivo [10–12]. Another group of fructose polymers,
levans (β-2,6-D-fructans), synthesized mostly by microorganisms but also by some plants are
naturally present in various food products and consumed by humans in low quantities [13].
Microbial levans are more advantageous, economically and industrially feasible compounds
with numerous applications. Levan is currently produced by many companies around the
world and it is used in foods, beverages, medicine and nanotechnology [14,15]. However, levan
is currently not in common use in Europe. With excellent biocompatibility and ease of produc-
tion, microbial levan appears as a valuable and versatile biopolymer of the future [14]. We con-
sider that levan should act as a selective growth substrate for gastrointestinal microbiota since
β-2,6 glycosidic bonds characteristic for levan can be cleaved by only few bacterial species. For
example, from tested Bacteroides species, only strains of B. thetaiotaomicron are able to grow
on levan [16].
Many bacterial species including Zymomonas mobilis, Bacillus subtilis and Lactobacillus reu-
teri harbor levansucrase and synthesize levan from sucrose. Levan used in the current study
was prepared using levansucrase Lsc3 of Pseudomonas syringae pv. tomato DC3000 [13] as
described by Adamberg et al. [17] and subsequently dialyzed to remove residual amount of
mono- and disaccharides.
The growth dynamics and metabolism of microbial consortia can be studied by using vari-
ous cultivation techniques from simple batch to advanced continuous fermentations [18],
whilst simpler methods with higher throughput are preferred for screening purposes. Due to
the relative simplicity and cost-effectiveness the use of isothermal microcalorimetry (IMC) in
biological and biomedical fields such as detection and characterization of pathogens, drug test-
ing, parasitology and tissue engineering has been increasing over the last ten years [19]. The
production rate of heat that reflects the cellular metabolic activities is measured on-line in case
of IMC [20,21]. Sensitivity of this method compares well with commonly used techniques, and
given proper data analysis, calorimetric data can be translated into meaningful biological
equivalents (for example length of lag phase, growth and substrate consumption rate) [21].
IMC has proven especially useful, when dealing with opaque, solid, semi-solid or encapsulated
samples [22]. Mathematical comparison of the power-time curves can allow identification of
microorganisms or can simply be used for quality control purposes (i.e., a measure of the varia-
tion of a specific process monitored using its associated thermal power curve) [21].
The aim of the current study was to elucidate the modulatory effect of levan on the composi-
tion and dynamics of consortia of fecal bacteria using a novel approach on this field: microcalo-
rimetry linked to metabolite profiling and microbiome characterization.
Levan Degradation by Fecal Microbiota
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Materials and Methods
Fecal samples and levan
Eleven fecal samples were donated by healthy Estonian adult subjects (mean age 32 ± 12 years).
The fecal samples were collected into sterile 25 ml feces sampling containers (APTACA,
Italy) and kept under anaerobic environment in a gas generating pouch system (GasPak™, Bec-
ton Dickinson & Co, USA) at -20°C. Frozen samples were delivered to the laboratory within
48 h and stored at -80°C until processing (no longer than three weeks). The storage cultures
were prepared aseptically in a glove box flushed with nitrogen gas. The stool sample was
diluted five times with sterile anaerobic PBS (mM): NaCl (160), KCl (3), Na2HPO4 (8),
NaH2PO4 (1), containing 5% dimethylsulfoxide (DMSO) (vol/vol), pH 7.2, supplemented with
freshly made and filter sterilized Cys-HCl (0.05% in final solution). The diluted samples were
stored at -80°C as aliquots (5 ml) sufficient to start a cultivation experiment.
Levan was produced from sucrose using Lsc3 from P. syringae DC3000 and precipitated
with ethanol as shown previously in Adamberg et al. [17]. To remove low molecular weight
compounds including mono- and disaccharides, levan was dissolved in MQ water and dialyzed
for 36 h at room temperature in membrane tubing of 20 kDa molecular weight cut-off against
sterile milliQ water. The dialyzed levan preparation was freeze-dried (VirTis freeze dryer, SP
Industries Inc., Warminster, USA).
Isothermal microcalorimetry (IMC)
The growth experiments were performed as described in Adamberg et al. with some modifica-
tions [17]. The base medium for growth experiments contained: 0.05 M potassium phosphate
buffer made from 1 M stock solutions (ml/L): K2HPO4 (35.85) and KH2PO4 (14.15) and min-
eral salts (mg/L): MgSO47H2O (36), FeSO47H2O (0.1), CaCl2 (9), MnSO4H2O (3),
ZnSO47H2O (1), CoSO47H2O (1), CuSO45H2O (1), MgCl2 (2), (NH4)6Mo7O244H2O (1),
NaCl (527), (NH4)Cl (400); without and with levan (5 g/L) as a carbon source; pH 7.2.
The M20 medium contained additional amino acids and vitamins and it was supplemented
with levan (5 g/L) [15]. Before inoculation, the growth media were prereduced in an anaerobic
jar (Anaero-Gen™, Oxoid Inc.,UK), supplemented with stock solutions of freshly prepared and
filter-sterilized Cys-HCl (concentration in the medium 0.5 g/L) and autoclaved sodium thio-
glycolate (concentration in the medium 0.5 g/L) as reducing agents. The media were inoculated
with aliquots prepared from frozen feces to obtain approximately 10–100 times dilution.
The ampoules with total volume of 3.3 ml were filled with 2 ml of inoculated medium,
closed hermetically and incubated at 37°C in a 24-channel isothermal microcalorimeter TAM
III (TA Instruments, Delaware, USA) as described by Kabanova et al. [23]. The heat flow (P,
μW) was recorded and total accumulated heat (Q, J) which is proportional to generated bio-
mass was calculated by integration of the heat flow. All fecal samples were tested at least in two
independent calorimetry experiments with two technical replicates in each experiment.
Determination of metabolites
At the end of 48 h-incubation, the gas sample was taken for the composition analysis before
opening the ampoule. Gas composition (H2, CO2, H2S, CH4, and N2) of the head space of the
ampoules was analyzed using the Agilent 490 Micro GC Biogas Analyzer (Agilent 269 Technol-
ogies Ltd., USA) coupled with thermal conductivity detector as described in Adamberg et al.
[17].
Samples from the beginning and end of the growth experiments were analyzed for microbial
16S rDNA sequences, metabolites and pH. The samples were centrifuged (21000 g, 10 min),
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pellet and supernatant were separated and stored at -20°C until the analysis. 10% sulfosalicylic
acid (1:0.25; vol/vol) was added to the supernatant before freezing. Bacterial DNA was analyzed
from cell pellets.
Before the chromatographic analysis, the samples were centrifuged (21000 g, 15 min, 4°C)
and the supernatants were filtered through 0.20 μm PTFE syringe filters (Millex filters
SLLGH13NK, Millipore, USA). The samples of fecal homogenate with high polysaccharide
and/ or levan content were additionally ultra-filtered using AmiconR Ultra-10K Centrifugal
Filter Devices, cut-off 10 kDa (Millipore, USA). The concentrations of organic acids (succinate,
lactate, formate, acetate, propionate, isobutyrate, butyrate, isovalerate, valerate), glycerol and
ethanol were determined by high-performance liquid chromatography (HPLC, Alliance 2795
system, Waters, Milford, MA, USA), using a BioRad HPX-87H column (Hercules, CA, USA)
with isocratic elution of 0.005 M H2SO4 at a flow rate of 0.6 mL/min and at 35°C. Refractive
index (RI) (model 2414; Waters, USA) and UV (210 nm; model 2487; Waters, USA) detectors
were used for quantification of the substances. Detection limit for the HPLC method was
0.1 mM.
Concentrations of amino acids and amines were determined using pre-column derivatiza-
tion of amino acids and amines by 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate and
UPLC (Waters, Milford, USA) according to the manufacturer’s instructions. Empower soft-
ware (Waters, USA) was used for the processing of HPLC and UPLC data. Detection limit of
the UPLC was 0.01 mM.
Total content of levan in the supernatants was determined by anthrone assay as described in
Adamberg et al. [17]. Standards containing 5–100 mg/L fructose and 0.6 M HCl (final concen-
tration) in deionized water were analyzed with each run. To account for the absorbance due to
stool components, a second blank was introduced made by adding sulphuric acid reagent with-
out anthrone, when the final dilution of feces in the sample was 1:100 or less. All measurements
were performed in triplicate.
DNA extraction and amplification
DNA was extracted from all samples using MoBio PowerFecal DNA extraction kit (MoBio,
Carlsbad, CA, USA) according to the manufacturer’s instructions. Universal primers:
S-D-Bact-0341-b-S-17 Forward 5´ TCGTCGGCAGCGTCAGATGTGTATAAGAGA
CAGCCTACGGGNGGCWGCAG F and
S-D-Bact-0785-a-A-21 Reverse 5´ GTCTCGTGGGCTCGGAGATGTGTATAAGAGA
CAGGACTACHVGGGTATCTAATCC were used for PCR amplification of the V3-V4 hyper-
variable regions of the 16S rRNA genes [24]. The amplified region was about 450 bp and on
average 12000 reads per sample were obtained. The mixture of amplicons was pyrosequenced
using Illumina MiSeq 2x250 v2 platform (Microsynth AG, Switzerland).
Taxonomic profiling of fecal samples
The sequencing data were analyzed using the program MOTHUR v1.35.0 according to the
instructions of standard operating procedure [25,26]. PCR errors and reads shorter than 400
bp or containing more than eight homopolymers were removed from the dataset. Sequences
were aligned to the SILVA reference 16S rRNA database and clustered into Operational Taxo-
nomic Units (OTUs) according to average neighbor clustering algorithm based on 97%
sequence identity. Finally, the dataset of each sample was normalized according to the sample
with lowest quantity of sequences. The taxonomy of each OTU was assigned using SILVA 16S
rRNA database (v119) (or the Greengenes database v13.5).
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Statistical analysis
For multivariate analysis, data of all experiments (abundances of bacterial taxa, growth charac-
teristics from calorimetry and metabolites’ production/consumption) were merged into a
matrix table. Partial least squares discriminant analysis (PLS-DA) of the data was performed
using web-based software MetaboAnalyst 3.0 [27].
Ethics statement
During a preparatory consultation interview, the volunteers were informed about the scope of
research and all the subjects gave written informed consent. The study was approved by the
Tallinn Medical Research Ethics Committee, Estonia (protocol No. 554).
Results
Growth dynamics based on power-time curves and 16S analysis of the
bacterial consortia
In total, 325 operational taxonomic units (OTU-s) with a relative abundance over 0.1% were
found in at least one out of 11 fecal samples. Initial compositions of all eleven fecal consortia
(FS1–11) were dominated (abundance over 50%) by species from the phylum Firmicutes. The
major taxa represented in the samples belonged to Ruminococcaceae, Lachnospiraceae, Dialis-
ter, Faecalibacterium, Pseudobutyrivibrio, Subdoligranulum, Blautia, Prevotella, Bifidobacter-
ium, Coprococcus (Fig 1A, S1 Table). Interestingly, the genus Dialister was dominating in five
fecal samples (FS1, FS3, FS4, FS7 and FS9), yet no enrichment of this taxon was observed dur-
ing cultivation with levan or levan plus amino acids. According to the literature, Dialister invi-
sus has been associated with human clinical samples and infections [28]. Recently Dialister,
Roseburia and Bifidobacterium genera were shown to be enriched among fecal microbiota by
diet including whole-grain barley [29].
The growth experiments using fecal inocula were performed in defined media containing
either 20 amino acids or only Cys with or without levan. The heat generation (biomass growth)
of control cultures (base medium without levan and additional amino acids) depended on the
amount of residual substrates (complex carbohydrates and proteins) in the fecal material acces-
sible to microorganisms during the incubation. Taking into account the theoretical energy gain
from carbohydrate fermentation in anaerobic environment and content of 20 amino acids
added to the medium (in total 0.86 g/L), at least 2 g/L of fermentable substrates should be pres-
ent in 10% fecal slurry (corresponds to approximately 10% of the initial fecal dry mass if dry
matter in feces is 25% [30]).
Addition of 5 g/L of levan to basic medium significantly increased the growth of fecal bio-
mass (up to 0.47 gDW/L; DW, dry weight) when compared to cultures without any carbon
source added (up to 0.23 gDW/L, Fig 2). The main taxa enriched in levan-supplemented cul-
tures comprised Bacteroides, Streptococcus, Ruminococcus, Erysipelotrichaceae, Collinsella, Fae-
calibacterium and Coriobacteriaceae. In addition, supplementation of levan + 20 amino acids
supported growth of Lactobacillus, Eubacterium, Subdoligranum, Oscillospira and Clostridium.
Bifidobacteria and Enterobacteriaceae were competitive in cultures with levan + amino acids,
but remained in minority when grown on levan only, whilst Erysipelotrichaceae was not com-
petitive in cultures with levan + amino acids (Fig 1B).
The fecal samples studied here were divided into two subgroups according to the obtained
calorimetric curves exhibiting either a) multiauxic growth or b) growth with single major
power peak in levan-supplemented media as well as in media without any carbon source added
(Fig 2, complete data in S2 Table). The multiauxic growth on levan started with a small power
Levan Degradation by Fecal Microbiota
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Fig 1. Bacterial taxa in individual fecal samples and their abundance after the growth in
microcalorimeter. (A) 22 bacterial taxa of fecal samples (FS1-11) with average abundance 1% are shown
(sum of reads in relative scale, %). (B) abundance of genera (family/order level if the genus was not
identified) per million cells (1 read = 1 cell) after growth on levan (red dots), levan plus amino acids (green
triangles) or without added substrates (blue rectangles) in a logarithmic scale. All data points presented as
Levan Degradation by Fecal Microbiota
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peak (less than 100 μW) followed by prolonged major growth phase (samples FS1 and FS3-5).
In the second group, initial growth on levan was fast with high heat evolution rate (Pmax up to
600 μW), and no distinct growth were further observed. The growth curves in medium
average values of all fecal samples. *—statistical difference between the samples with levan and without
added substrates (p-value < 0.05), **—statistical difference between the samples with levan and levan +
amino acids (p-value < 0.05).
doi:10.1371/journal.pone.0144042.g001
Fig 2. Growth characteristics of fecal consortia onmedia of varied composition. (A) Growth of fecal cultures from group I (FS1-5) on medium without
levan and amino acids. (B) Growth of fecal cultures from group II (FS6-11) on medium without levan and amino acids. (C) Growth of fecal cultures from group
I on medium with levan. (D) Growth of fecal cultures from group II on medium with levan. μ - specific growth rate (h-1), Q—heat accumulated (J) and Pmax—
maximum heat evolution rates (power, μW) achieved in different growth phases. Growth phase is defined as time between the power peak maxima, i.e. each
power peak divides growth into two phases: before and after power peak maximum. Error bars indicate standard deviation of 2–4 biological replicates. Line
graphs illustrate the heat evolution rate (P–power, μW) during the whole experiment. Note that line graphs on consortia growth with and without levan have
different Y axis scale.
doi:10.1371/journal.pone.0144042.g002
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containing levan and twenty amino acids were similar to those with levan only (S2 Table, not
shown in Fig 2). When compared with levan-supplemented media, the power-time curves on
residual fecal substrates (without any substrates added) were more diverse displaying either a)
several distinct growth phases (samples FS1-5), or b) only one plateau-like phase (samples FS6-
10) with only small first power peak and total heat accumulation being significantly smaller
(Fig 2A and 2B). The multiauxic heat evolution suggests that the excreted fecal material con-
tains several types of substrates (mostly undigested carbohydrates and proteins) and reflects
the flexibility of microbial consortia to switch from utilization of one substrate to another. In
case of fecal cultures without added substrates, overgrowth of presumably proteolytic species
from genera Escherichia/Shigella was observed. The total produced heat (sum of heat produced
during different phases, Fig 2C and 2D) at growth in levan-containing medium varied about
two times between different fecal samples (7.9±1.1 to 17.8±0.5 J) whilst much larger variation
between the samples was observed if the consortia were growing on residual substrates only
(1.6±0.9 to 5.7±2.1 J). This sample-specific feature possibly characterizes the energetic potential
of the individual’s diet and/or efficiency of the colon microbiota to extract metabolic energy
from undigested food components reaching the colon.
Metabolism of carbohydrates and amino acids by fecal consortia
The main fatty acid found in fecal samples donated was acetate (3.1±1.1 mmol/gDW as average
for 11 samples) followed by propionate and butyrate (0.6±0.5 and 0.5±0.4 mmol/gDW, respec-
tively, Table 1). Minor amounts of succinate and isobutyrate (below 0.1 mmol/gDW) were also
detected. Molar ratios 50:7:9 of acetate, propionate and butyrate in samples analyzed in this
study were comparable to 42:16:14 ratios presented in Cummings et al. [31]. Fecal samples
contained also small amounts of free amino acids, ranging from 0.002±0.002 (Trp) to 0.14±
0.08 (Glu) mmol/g, γ-aminobutyric acid (GABA) and biogenic amines (see S3 Table).
Although the heat evolution curves at growth of fecal samples did not remarkably differ
between the media containing levan or levan + amino acids, consumption or production pro-
files of metabolites differed significantly (Fig 3). During the incubation levan was completely
consumed when considering the sum of formed products and only trace amounts of fructose
(levan degradation product) were detected by anthrone assay (data not shown). At growth of
fecal consortia on levan, mainly acetic and lactic acids (76±12 and 63±19 mmol/gDW, respec-
tively, average confidence interval ±95%, Fig 3A) and about 2–3 times smaller amounts of
Table 1. Content of organic acids in fecal cultures (μmol/g±SD) analyzed before each cultivation experiment (2–4 calorimetry replicates per sam-
ple). Complete data shown in the S3 Table.
Culture Acetate Butyrate Isobutyrate Propionate Succinate
FS1 51.1 ± 3.2 10.7 ± 1.3 0.7 ± 1.0 14.4 ± 0.7 1.0 ± 0.4
FS2 25.5 ± 3.5 3.8 ± 1.8 2.0 ± 3.0 4.2 ± 2.2 1.5 ± 0.7
FS3 19.3 ± 2.4 3.8 ± 0.8 1.5 ± 2.2 2.2 ± 1.9 0.5 ± 0.5
FS4 46.2 ± 6.8 9.2 ± 1.2 2.9 ± 4.3 8.5 ± 1.9 2.4 ± 0.9
FS5 24.5 ± 1.0 4.3 ± 0.5 0.8 ± 1.3 5.8 ± 1.2 1.4 ± 0.5
FS6 23.3 ± 5.2 1.2 ± 0 0 ± 0 2.3 ± 2.3 0.3 ± 0.3
FS7 49.4 ± 0.8 9.5 ± 0 0.5 ± 0.5 16.3 ± 1.1 4.9 ± 0
FS8 27.7 ± 5.1 2.7 ± 0 1.0 ± 1.0 3.5 ± 2.2 0.3 ± 0.3
FS9 23.3 ± 2.4 1.5 ± 0 0.4 ± 0.4 4.8 ± 2.1 2.9 ± 0.3
FS10 25.5 ± 5.4 5.0 ± 0 0.1 ± 0.1 3.7 ± 2.7 0.3 ± 0.3
FS11 24.9 ± 0.2 1.2 ± 0 0 ± 0 2.8 ± 1.4 0.7 ± 0.2
doi:10.1371/journal.pone.0144042.t001
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butyric and propionic acids were formed. This result indicates simultaneous growth of bacteria
producing those acids such as streptococci, Escherichia, Bacteroides, Collinsella, Faecalibacter-
ium, Eubacterium and Catenibacterium (Fig 1B). To give a comparison, the molar ratios of ace-
tate:propionate:butyrate were about 72:19:8 in case of growth of fecal batch cultures on inulin,
and 58:18:25 on starch as reported by Wang and Gibson [11]. In our study equimolar produc-
tion of acetic and lactic acids refers to the possibility that lactate was not completely fermented
to butyrate or propionate, most probably due to accumulation of acids and decrease of pH. The
level of acidity is a crucial factor for determination of growth and metabolism of gut microbiota
[32,33]. The pH of the control cultures without additional substrates used was decreased at
most by 1.5 units (from 7.1 to 5.6), whereas in levan-supplemented cultures it decreased to
4.7–5.2 (data not shown).
Small amounts of detected CO2 may indicate that anabolic routes from phosphoenolpyr-
uvate to oxaloacetate or reductive TCA cycle were active, and thus intermediates of the TCA
cycle were used for the biosynthesis or exported as unidentified compounds. Indeed, in accor-
dance with this, we could not identify some peaks in HPLC chromatograms, and based on the
model calculations the total carbon shortage was on average 15 C-mmol/L (difference between
the total carbon consumed and total carbon produced in case of growth at levan supplementa-
tion was 150 C-mmol/L).
Amino acid synthesis should also be considered, because they were neither remarkably con-
sumed nor produced in cultures in the presence of levan. Additional amino acid supply signifi-
cantly affected central metabolism as well as amino acid metabolism (Fig 3). Degradation of
amino acids to isobutyrate and biogenic amines was more intensive at growth in levan-contain-
ing medium supplemented with 20 amino acids compared to that in levan-containing medium
with only Cys added (Fig 3B). Active amino acid degradation was accompanied with increased
production of acetate, succinate and formate. The amino acids with highest consumption rates
in M20 medium were Ser, Glu, Asp and Lys. The only amino acid produced in significant
amounts in all experimental conditions was Ala (1.7, 2.3 and 5.3 mmol/gDW in media with
levan, levan + 20 amino acids and without the added carbon source, respectively). Addition of
amino acids also affected the dynamics of bacterial population by enhancing the growth of Lac-
tobacillus, Eubacterium and Subdoligranulum, which was not observed in the medium contain-
ing only levan (Fig 1B).
During incubation of fecal slurries with neither levan nor amino acids added, mainly acetate
was produced (177±81 mmol/gDW), while propionate and butyrate were produced in minor
amounts (25±12 and 23±10 mmol/gDW, respectively, Fig 3A). Glu and Ser were significantly
consumed whereas Ala was produced when grown on levan + amino acids (Fig 3C). Notably,
biogenic amines were produced at significantly larger amounts during growth of fecal consortia
without levan (Fig 3B) suggesting proteolysis of residual proteins present in fecal slurry as con-
sumption of Lys, Arg, Tyr and Trp was not observed (Fig 3C, S4 Table). In the medium without
added levan Ile, Val and Leu were also produced (S4 Table), which might be the result of
hydrolysis of the proteins. Alternatively, synthesis of these amino acids may be promoted for
reoxidation of coenzymes as in the case of Ala production in anaerobic bacterial fermentations
Fig 3. Production of organic acids, carbon dioxide and ethanol (A), biogenic amines and branched-
chain fatty acids (B), and production/consumption of amino acids (C) (mmol/gDW) during growth of
fecal consortia in media containing levan (in red), levan + amino acids (in green) or without added
substrates (in blue). The data presents the average of all fecal samples (n = 11 with 1–4 biological
replicates). Dotted line indicates the zero level (no production or consumption). *—significant difference
between levan and no-substrate conditions (p-value < 0.05), **—significant difference between levan and
levan + amino acids (p-value < 0.05), ***—significant difference between levan and levan + amino acids and
no substrate conditions (p-value < 0.05).
doi:10.1371/journal.pone.0144042.g003
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and growth of Aspergillus nidulans in hypoxic conditions [34]. In levan-supplemented medium
the fecal bacteria most likely use other possibilities to maintain the redox balance. The metabo-
lites detected at growth in the absence of levan refer to domination of proteolytic bacteria such
as Enterobacteriaceae, and suppression of butyric acid producing bacteria such as Faecalibac-
terium and Ruminococcus. Specific groups of bacteria detected only in medium without the
addition of levan and amino acids were Christensenellaceae, Catenibacterium and Alistipes.
Discussion
Levan-induced changes in growth dynamics, metabolism and bacterial
composition of fecal samples
The effect of β-2,1-linked fructans, inulin and FOS (fructooligosaccharides), on gut microbiota
has been thoroughly studied [[10–12]]. Here we present the results on how a β-2,6-linked fruc-
tan levan and varied amino acid supplementation shapes the composition and metabolism of
fecal microbiota. Our data obtained here support the data and opinion of other researchers
[35,36] showing that degradation and metabolism of carbohydrates in complex microbial eco-
systems proceeds through cross-feeding, and that the profile of end products is determined not
only by the composition and structure of the degradable substrates, but also by composition of
the consortium.
Addition of levan clearly promoted growth of fecal microbiota (Fig 2C and 2D). Two dis-
tinct fermentation subtypes were observed during growth of fecal cultures in levan-containing
medium. In the case of the first subtype (Type I, samples FS1-5), growth proceeded through
multiple phases: the fast minor growth phase was followed by several prolonged growth phases
with highest heat generation in the last phase. The heat evolution rate in all growth phases was
small and did not exceed 400 μW. The second subtype (Type II, samples FS6-11) can be char-
acterized by fast growth within the first 20 hours suggesting efficient adaptation of these micro-
bial consortia to assimilation of levan. Only a few growth phases were detected and most of the
heat accumulated during the first and second phases had high heat evolution rates (up to 600
W, Fig 2D). The initial bacterial composition of fecal subgroups I and II was rather similar:
from 22 dominant genera only the amounts of Pseudobutyrivibrio, Lachnospira and Dorea
were significantly different between the subgroups (Fig 1A, S1 Table). Considering that the
proportion of those bacterial groups did not increase during the fermentation either with or
without levan, we propose that the heat evolution was obviously not influenced by these genera.
The main genera enriched in levan-containing medium were Bacteroides, Escherichia, Strepto-
coccus and Ruminococcus. Importantly, several taxa that are potential butyrate-producing
bacteria such as Erysipelotrichaceae and Faecalibacterium were also enriched at levan supple-
mentation (Fig 1B).
The power-time curves at growth of fecal samples without added substrates (at the expense
of residual nutrient sources) reflect the amount of undigested components escaping human
digestive enzymes and thereby become accessible to colon microbes. Therefore, minimal heat
flow values of the fecal culture may refer to low consumption of dietary fiber by the fecal
donor, or on the other hand, high activity of colon microbes on fiber substrates consumed by
the resulting lower residual energy of feces. The experiments on gnotobiotic mice have indi-
cated the increase of intestinal energy extraction and concordantly reduced feces energy level
obtained from inulin compared to cellulose [12]. It should be elucidated in further experiments
if there is a correlation between residual energy in feces, composition and activity of the colon
microbiota and consumption of dietary fibers by the donor.
The main fermentation products from levan comprised acetic, lactic, butyric, propionic and
succinic acids and carbon dioxide. This suggests syntrophic growth of levan-degrading and
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butyrate producing bacteria. The rate of levan hydrolysis depends on abundance of levan-
degrading bacteria in the population. There are only few bacterial genera that harbor strains
possessing enzymes for levan degradation. Among the gut bacteria, B. thetaiotaomicron has the
most efficient and best characterized specialized enzymatic system (both endo- and exoleva-
nases) for levan degradation and utilization [16,17]. Some probiotic bacteria such as lactobacilli
and bifidobacteria can also catabolize levan. For example Lactobacillus paracasei has cell wall
bound aspecific exo-acting β-fructosidase that hydrolyzes levan, inulin and various FOS
[37,38]. Porras-Domiguez et al. [39] reported on growth of L. paracasei and also of four strains
of bifidobacteria on levan and levan-derived FOS. Several Bacillus species also possess genes for
levan-degradation [40]. The levan-degrading bacteria act in primary step of cascade reactions
leading to levan metabolism. The hydrolysis products, FOS and fructose, but also the excreted
metabolites such as organic acids and gases can be used by a variety of colon bacteria resulting
in specific metabolic patterns and microbiota dynamics. Based on the experimental data, the
metabolic flowchart and respective bacteria participating in degradation of levan and produc-
tion of metabolites was proposed (Fig 4). Importantly, we observed specific growth stimulation
of Faecalibacterium, Erysipelotrichaceae and Eubacterium by levan, the growth of these bacteria
was not supported in the medium without levan (Fig 1B).
A short first growth phase followed by a second long growth phase may indicate low initial
content of levan-degrading bacteria in the fecal sample (Fig 2). This assumption is supported
also by the enrichment of specific species from the consortia. Levan is degraded mainly by
some Bacteroides and Lactobacillus species, but following growth of butyrate-producing bacte-
ria (Faecalibacterium, Roseburia, Catenibacterium) and bifidobacteria, streptococci and Escher-
ichia indicates that fructose or FOS are efficiently fermented by these bacteria (Fig 1B).
Using a single fermenter system for cultivation experiments with fecal inocula, Duncan
et al. [41] showed that inulin can affect the growth of different bacterial groups. For example,
enrichment of Bacteroides strains and disappearance of Faecalibacterium prausnitzii was
Fig 4. Proposed scheme for levan degradation and product formation on the basis of our experimental data and information from the literature.
doi:10.1371/journal.pone.0144042.g004
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reported. In our study enrichment of taxon Faecalibacterium which is also regarded as an
abundant representative in healthy gut microbiota, was observed in fecal cultures grown on
levan and also on levan + amino acids.
Acidity (pH) has been shown to be a crucial factor that determines the growth and metabo-
lism of colon microbiota [32,33,41]. The main limitation of simple batch cultures such as IMC
experiments is that pH cannot be kept within a certain range. Formation of organic acids from
the complex carbohydrates leads to the drop of pH that affects enzyme activities of the
microbes and results in compositional changes. This may be the main reason of accumulation
of lactic acid in the end of growth and inhibition of its further fermentation to other acids. In
case of continuous cultures at pH 6.9 of the same fecal inocula, accumulation of lactic acid was
not observed (data not shown).
The experiments of Belenguer et al. [42] suggest that lactate is rapidly converted to acetate,
butyrate and propionate by the human intestinal microbiota at pH values as low as 5.9. How-
ever, at pH 5.2 reduced utilization occurs while production is maintained, resulting in lactate
accumulation. In addition, 100-fold increase in population of Eubacterium hallii, a lactate-uti-
lizing butyrate-producing bacterium was observed at pH 5.9 and 6.4. On the contrary, Walker
et al. showed that butyrate production by human fecal microbiota was higher at pH 5.5 com-
pared to that at pH 6.5 and it also depended on peptide supply [32]. While the growth of
Bacteroides was inhibited at lower pH, the isolates of Roseburia grew equally well at both pH-s.
In fecal samples from healthy donors, lactate has not detected or is present at low concentra-
tions (3 mmol/L) [42], due to its further metabolism in the colon. Since lactate is a major fer-
mentation product of several bacterial families it was proposed that it might contribute to
some of the properties attributed to probiotic microorganisms [43]. Still, lactate can modulate
inflammatory activation of the epithelial cells. Intraluminal levels of lactate derived from fer-
mentative metabolism of lactobacilli have been shown to modulate inflammatory environment
in intestinal mucosa [43].
Along with growing knowledge, the significance of proper sample collection, storage and
preparation techniques to obtain adequate results is increasing. Preservation and re-cultiva-
tions of live fecal cultures have been applied for FMT (fecal microbiota transplantation) proce-
dures [44,45]. No significant differences were detected between different sampling and storage
conditions (freezing vs cooling) on the bacterial community structure at DNA level by Tedjo
et al. [46]. Composition, growth and function of complex microbial consortia are most often
described on the basis of the metagenome or 16S rDNA sequencing data, however, for cultiva-
tion studies alive and metabolically active fecal cultures should be used. Thus, the growth
experiments are often performed with freshly collected fecal samples and typically not in bio-
logical replicates. Resuspension of fecal material in a dialysate solution supplemented with
glycerol and stored at -80°C was suggested by Aguirre et al. [47] as optimal preservation tech-
nique of fecal material for in vitro fermentations alternative to using fresh feces. We have
shown that fecal slurries in PBS containing 5% DMSO remain metabolically active when stored
at -80°C and can be used in repeated cultivation experiments. Chemical composition of the
fecal samples during at least 3 months of storage did not change (Table 1). Stability of the fro-
zen feces was also supported by small standard deviations of growth characteristics (Fig 2) cal-
culated from the power time curves (parallel experiments were made within a three month
period).
Proposed use of IMC for gut microbiota studies
Isothermal microcalorimetry (IMC) has been extensively used in studies of pure cultures
[17,21,23] and also for mixed cultures of two or three microbial strains [48]. Despite the
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difficulty in interpretation of the power-time curves of complex microbial consortia due to
multiple concurrent metabolic processes, IMC complemented with metagenomic and metabo-
lomic analysis provides the most sensitive approach to monitor the adjustment and develop-
ment of complex microbial populations under various nutritional conditions. Moreover,
significantly higher number (up to 48) of samples and/or environmental conditions can be
screened during the same run by using a multichannel calorimeter when compared to conven-
tional fermentation techniques. The latter method is definitely better suited for further detailed
metabolic analyses but not for initial screening.
A specific advantage of the IMC is applicability of the method to monitor growth in turbid
and solid environments (e.g. fecal slurries). Although direct correlation between the power-
time curves with the changes in consortia structure and metabolism may not exist, one can fol-
low the metabolism and dynamics of the colon microbiota on different substrates by combin-
ing the growth data with chemical and metagenomics analyses (Fig 5A). Our data show that
the growth of complex fecal microbial consortia is determined by multiple factors. The param-
eters with the highest impact in the case of using levan as the carbon source comprise the heat
accumulated, GABA and lactate production, and the growth of Faecalibacterium (Fig 5B).
Hence IMC is a promising method for comparing fermentation capacity of a persons’ individ-
ual gut microbiota on various carbohydrates either singly or in combinations. It can also be
applied for screening the day-to-day variation of the fermentation potential of a person, effect
of the diet and evaluation of residual energetic values in excreted material.
Compared to the ancient diet, the proportion of dietary fibers in our everyday food has dra-
matically decreased during the last century. It is generally accepted that restoring the variety
and amount of dietary fibers would be the easiest way to enrich and diversify the gut microflora
and thereby improve our health. In general, non-digestible oligosaccharides, in particular FOS,
Fig 5. Score plots of PLS-DA (A) and variable importance in projection (VIP) (B). Plots derived from integrated analysis of microcalorimetric data (total
heat accumulated (Q), maximal heat evolution rate (Pmax), specific growth rate (μ)), consumption of substrates (levan, amino acids) and formation of products
(organic acids, gases and ethanol), and the bacterial genera grown in microcalometry experiments. Analysis was done by MetaboAnalyst 3.0 program [25].
Levan+AA–medium containing levan and 20 amino acids. Groups I and II indicate the fecal samples of FS1-5 and FS6-11, respectively.
doi:10.1371/journal.pone.0144042.g005
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are considered as prebiotics [49]. For a long time prebiotic effects have been linked mostly to
enhancement of growth of bifidobacteria and lactobacilli. Literature data show that many
strains of both these bacteria can grow on levan [39]. From this aspect, levan should certainly
be considered as a potential candidate for prebiotic. In the current study we show that levan
also enhanced the growth of Faecalibacterium. This genus comprises F. prausnitzii, a butyrate-
producing species that is considered a new probiotic bacterium with excellent anti-inflamma-
tory properties [50]. We assume that levan may be suitable as selective substrate for this
bacterium.
Conclusions
The interactions taking part in the gut and their influences on human health are highly com-
plex and we are just in the beginning of understanding the mechanisms. The overall effects of
dietary fibers comprise modification of the whole microbial population of the gut by stimulat-
ing growth and metabolism of certain groups of bacteria (changing proportions and interac-
tions) and positively influencing metabolic fluxes leading to a diverse range of health benefits.
We showed here that metabolic potential of colon microbiota on specific substrates can be
evaluated by isothermal microcalorimetry coupled with product and consortia analysis. Using
this approach, the selective effect of known or predicted prebiotic substrates on specific bacte-
ria and/or groups within complex consortia can be revealed. Our experiments clearly indicated
a modulating effect of levan on human colon microbiota. The wider influence of this novel can-
didate prebiotic on human organism should be more thoroughly investigated using in vitro as
well as in vivomethods.
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